M32.15 identifies tubulo-interstitial nephropathy as the specific renal manifestation of systemic lupus erythematosus — distinct from glomerular disease — affecting the renal tubules and surrounding interstitium in the setting of confirmed SLE.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 0
- Region
- Other
Documentation tips
What should appear in the chart to support M32.15.
Source · Editorial brief grounded in 6 cited references ↓
- The provider must explicitly document tubulo-interstitial nephropathy — not just 'lupus nephritis' or 'renal involvement' — to support M32.15 over the less-specific M32.10 or M32.14.
- Include laboratory findings such as urinalysis, renal function tests (BUN, creatinine, GFR), and urine protein levels that distinguish TIN from glomerular disease.
- Biopsy results confirming tubulo-interstitial pattern should be referenced in the note; without histopathologic or strong clinical differentiation, auditors may flag M32.15 as unsupported.
- Document confirmed SLE diagnosis (ANA positivity, clinical criteria met) in addition to the renal manifestation — the code requires both conditions to be active and documented.
- Code any hypertension, anemia, or electrolyte disturbances attributable to TIN separately as additional diagnoses per ICD-10-CM coding conventions.
Common coding pitfalls
The recurring mistakes coders make with M32.15 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M32.15 interchangeably with M32.14 (glomerular disease in SLE) — these are clinically and histologically distinct; glomerulonephritis is not tubulo-interstitial nephropathy.
- Assigning M32.15 when documentation only states 'lupus nephritis' without specifying the nephropathy type — default to M32.14 for classic lupus nephritis or M32.10 if type is unspecified.
- Bypassing M32.15 entirely and coding M32.9 (SLE unspecified) when renal involvement is clearly documented — M32.9 is inappropriate once organ involvement is confirmed.
- Failing to add a code for the M32 Excludes1 note: discoid lupus erythematosus (L93.0) is excluded from the M32 category and should never be coded alongside M32.15.
- Not reporting concurrent comorbidities such as hypertension or CKD as additional diagnoses, leaving the claim under-coded and the clinical picture incomplete.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
Use M32.15 when the treating provider has documented SLE with confirmed tubulo-interstitial nephropathy (TIN) — the form of lupus renal involvement that targets the tubules and interstitium rather than the glomeruli. This is a distinct entity from M32.14 (glomerular disease in SLE); the two should not be used interchangeably. Biopsy findings or specific clinical documentation distinguishing TIN from glomerulonephritis are required to support M32.15 over M32.14.
M32.15 falls under M32.1 (SLE with organ or system involvement), so it requires confirmed organ involvement — not suspected. If renal involvement is documented but the specific nephropathy type is not yet characterized, use M32.10 (organ/system involvement unspecified) or M32.19, not M32.15. Drop to M32.9 only when no organ involvement of any kind is documented.
This code is most commonly encountered in rheumatology, nephrology, and internal medicine encounters, but orthopedic and multi-specialty practices managing SLE patients — particularly those with comorbid musculoskeletal disease — need it for accurate comorbidity coding. Always code additional conditions such as hypertension (if present) separately, per ICD-10-CM conventions for SLE with systemic involvement.
Sibling codes
Other billable codes under M32.1 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What is the difference between M32.15 and M32.14?
02Can I use M32.15 if the note says 'lupus nephritis' without specifying the type?
03When should I use M32.10 instead of M32.15?
04Should additional diagnosis codes be added alongside M32.15?
05Is discoid lupus coded with M32.15?
06Does M32.15 require a 7th character extension?
07Can an orthopedic practice legitimately report M32.15?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M30-M36/M32-/M32.15
- 03outsourcestrategies.comhttps://www.outsourcestrategies.com/blog/how-report-systemic-lupus-erythematosus-with-correct-icd-10-codes/
- 04the-rheumatologist.orghttps://www.the-rheumatologist.org/article/use-of-unspecified-codes-in-icd-10-what-you-need-to-know/
- 05aapc.comhttps://www.aapc.com/codes/icd-10-codes/M32.15
- 06icdcodes.aihttps://icdcodes.ai/diagnosis/lupus/documentation
Mira AI Scribe
The Mira AI Scribe captures the nephrologist's or rheumatologist's documented distinction between tubulo-interstitial and glomerular renal disease, pulling biopsy references, relevant lab values (GFR, creatinine, urine protein), and the confirmed SLE diagnosis into the encounter note. This prevents a coder from defaulting to the less-specific M32.14 or M32.10 and eliminates the audit risk that comes from claiming a highly specific nephropathy subtype without supporting clinical evidence in the record.
See how Mira captures M32.15 documentation